Blueprint Medicines Corporation (BPMC) vs Denali Therapeutics Inc. (DNLI)
Detailed comparison between Blueprint Medicines Corporation, Denali Therapeutics Inc..Total Return (%)
Blueprint Medicines Corporation (BPMC)Denali Therapeutics Inc. (DNLI)
Which stock do you think will perform better?
Blueprint Medicines Corporation
BPMC
Denali Therapeutics Inc.
DNLI
| Metric | Blueprint Medicines Corporation (BPMC) | Denali Therapeutics Inc. (DNLI) |
|---|---|---|
| Current Price | $129.46 | $14.21 |
| Change | 0.00 (0.00%) | -0.32 (-2.20%) |
| Market Cap | $8.37B | $2.06B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -137.72 | -5.17 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $129.55 | $33.33 |
| 52-Week Low | $73.04 | $10.57 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.51 | $-2.67 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BPMC | 0.98% | 15.63% | 12.60% | 65.06% | 308.26% | 308.26% |
| DNLI | 2.30% | -38.32% | -33.78% | -49.70% | -33.75% | -33.75% |